ABCAM PLC-SPON ADR (ABCM) Stock Fundamental Analysis
USA - NASDAQ:ABCM - US0003802040 - ADR
23.99 USD
+0.01 (+0.04%)
23.99 USD
0 (0%)
ABCM gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 531 industry peers in the Biotechnology industry. ABCM has only an average score on both its financial health and profitability. ABCM is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
In the past year ABCM was profitable.
ABCM had a positive operating cash flow in the past year.
1.2 Ratios
ABCM has a Return On Assets of 0.64%. This is amongst the best in the industry. ABCM outperforms 93.86% of its industry peers.
With an excellent Return On Equity value of 0.93%, ABCM belongs to the best of the industry, outperforming 93.86% of the companies in the same industry.
ABCM's Return On Invested Capital of 1.98% is amongst the best of the industry. ABCM outperforms 94.69% of its industry peers.
ABCM had an Average Return On Invested Capital over the past 3 years of 6.00%. This is significantly below the industry average of 15.76%.
The 3 year average ROIC (6.00%) for ABCM is well above the current ROIC(1.98%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.64% | ||
| ROE | 0.93% | ||
| ROIC | 1.98% |
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
1.3 Margins
The Profit Margin of ABCM (1.94%) is better than 94.86% of its industry peers.
ABCM's Profit Margin has declined in the last couple of years.
ABCM has a Operating Margin of 8.70%. This is amongst the best in the industry. ABCM outperforms 95.36% of its industry peers.
In the last couple of years the Operating Margin of ABCM has declined.
The Gross Margin of ABCM (72.69%) is better than 83.58% of its industry peers.
ABCM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.7% | ||
| PM (TTM) | 1.94% | ||
| GM | 72.69% |
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ABCM is destroying value.
The number of shares outstanding for ABCM has been increased compared to 1 year ago.
The debt/assets ratio for ABCM has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 8.64 indicates that ABCM is not in any danger for bankruptcy at the moment.
ABCM's Altman-Z score of 8.64 is amongst the best of the industry. ABCM outperforms 85.41% of its industry peers.
ABCM has a debt to FCF ratio of 19.99. This is a negative value and a sign of low solvency as ABCM would need 19.99 years to pay back of all of its debts.
ABCM has a better Debt to FCF ratio (19.99) than 94.03% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that ABCM is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.30, ABCM is doing worse than 71.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 19.99 | ||
| Altman-Z | 8.64 |
ROIC/WACC0.22
WACC8.89%
2.3 Liquidity
ABCM has a Current Ratio of 1.26. This is a normal value and indicates that ABCM is financially healthy and should not expect problems in meeting its short term obligations.
ABCM's Current ratio of 1.26 is on the low side compared to the rest of the industry. ABCM is outperformed by 86.73% of its industry peers.
A Quick Ratio of 0.98 indicates that ABCM may have some problems paying its short term obligations.
ABCM's Quick ratio of 0.98 is on the low side compared to the rest of the industry. ABCM is outperformed by 88.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
ABCM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 402.64%, which is quite impressive.
The earnings per share for ABCM have been decreasing by -17.30% on average. This is quite bad
The Revenue has grown by 17.70% in the past year. This is quite good.
The Revenue has been growing by 11.64% on average over the past years. This is quite good.
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS Q2Q%191.67%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Sales Q2Q%23.3%
3.2 Future
ABCM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.12% yearly.
ABCM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.28% yearly.
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 44.43, the valuation of ABCM can be described as expensive.
ABCM's Price/Earnings ratio is rather cheap when compared to the industry. ABCM is cheaper than 94.69% of the companies in the same industry.
ABCM's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.91.
A Price/Forward Earnings ratio of 49.32 indicates a quite expensive valuation of ABCM.
Based on the Price/Forward Earnings ratio, ABCM is valued cheaply inside the industry as 94.53% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 34.57. ABCM is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.43 | ||
| Fwd PE | 49.32 |
4.2 Price Multiples
94.20% of the companies in the same industry are more expensive than ABCM, based on the Enterprise Value to EBITDA ratio.
ABCM's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ABCM is cheaper than 93.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 374.67 | ||
| EV/EBITDA | 55.61 |
4.3 Compensation for Growth
ABCM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of ABCM may justify a higher PE ratio.
A more expensive valuation may be justified as ABCM's earnings are expected to grow with 52.49% in the coming years.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y68.04%
EPS Next 3Y52.49%
5. Dividend
5.1 Amount
ABCM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
23.99
+0.01 (+0.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners1.79%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.49B
Revenue(TTM)350.40M
Net Income(TTM)6.80M
Analysts80
Price Target20.23 (-15.67%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.43 | ||
| Fwd PE | 49.32 | ||
| P/S | 12.3 | ||
| P/FCF | 374.67 | ||
| P/OCF | 79.64 | ||
| P/B | 5.92 | ||
| P/tB | 42.37 | ||
| EV/EBITDA | 55.61 |
EPS(TTM)0.54
EY2.25%
EPS(NY)0.49
Fwd EY2.03%
FCF(TTM)0.06
FCFY0.27%
OCF(TTM)0.3
OCFY1.26%
SpS1.95
BVpS4.05
TBVpS0.57
PEG (NY)0.35
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.64% | ||
| ROE | 0.93% | ||
| ROCE | 3.54% | ||
| ROIC | 1.98% | ||
| ROICexc | 2.23% | ||
| ROICexgc | 7.95% | ||
| OM | 8.7% | ||
| PM (TTM) | 1.94% | ||
| GM | 72.69% | ||
| FCFM | 3.28% |
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
ROICexc(3y)7.76%
ROICexc(5y)11.54%
ROICexgc(3y)24.8%
ROICexgc(5y)47.7%
ROCE(3y)9.88%
ROCE(5y)14%
ROICexgc growth 3Y-57.08%
ROICexgc growth 5Y-37.19%
ROICexc growth 3Y-42.21%
ROICexc growth 5Y-23.94%
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
F-Score5
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 19.99 | ||
| Debt/EBITDA | 2.79 | ||
| Cap/Depr | 90.64% | ||
| Cap/Sales | 12.16% | ||
| Interest Coverage | 9.53 | ||
| Cash Conversion | 69.81% | ||
| Profit Quality | 169.12% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | 8.64 |
F-Score5
WACC8.89%
ROIC/WACC0.22
Cap/Depr(3y)181.11%
Cap/Depr(5y)191.67%
Cap/Sales(3y)16.16%
Cap/Sales(5y)14.67%
Profit Quality(3y)125.12%
Profit Quality(5y)105.69%
High Growth Momentum
Growth
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS Q2Q%191.67%
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Sales Q2Q%23.3%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%
EBIT growth 1Y-18.45%
EBIT growth 3Y-22.8%
EBIT growth 5Y-5.74%
EBIT Next Year197.84%
EBIT Next 3Y63.16%
EBIT Next 5Y39.34%
FCF growth 1Y-42.5%
FCF growth 3Y-17.2%
FCF growth 5Y-14.26%
OCF growth 1Y66.98%
OCF growth 3Y4.34%
OCF growth 5Y8.73%
ABCAM PLC-SPON ADR / ABCM FAQ
Can you provide the ChartMill fundamental rating for ABCAM PLC-SPON ADR?
ChartMill assigns a fundamental rating of 6 / 10 to ABCM.
What is the valuation status for ABCM stock?
ChartMill assigns a valuation rating of 7 / 10 to ABCAM PLC-SPON ADR (ABCM). This can be considered as Undervalued.
How profitable is ABCAM PLC-SPON ADR (ABCM) stock?
ABCAM PLC-SPON ADR (ABCM) has a profitability rating of 8 / 10.
What is the earnings growth outlook for ABCAM PLC-SPON ADR?
The Earnings per Share (EPS) of ABCAM PLC-SPON ADR (ABCM) is expected to grow by 125.95% in the next year.
Is the dividend of ABCAM PLC-SPON ADR sustainable?
The dividend rating of ABCAM PLC-SPON ADR (ABCM) is 0 / 10 and the dividend payout ratio is 0%.